1+ mon, 2+ week ago   (695+ words) The late-stage biotech has secured funding to advance first potential drug therapy for blinding corneal disease through the clinic. Claris Biotherapeutics is setting its sights on a breakthrough in ophthalmology. The company announced has closed a $118 million Series B financing…...

1+ mon, 2+ week ago   (896+ words) Experts discuss how GTN management has evolved from a primarily financial exercise to a cross-functional imperative where patient services teams play a critical role. In a recent webinar hosted by ConnectiveRx, industry veterans Chris Dowd, ConnectiveRx’s senior vice president, market…...

1+ mon, 2+ week ago   (1251+ words) In an industry where CDMOs have traditionally operated as transactional service providers, KBI Biopharma told us how it is charting a fundamentally different course. Founded 30 years ago as an analytical method services (AMS) focused firm, KBI has evolved into what…...

1+ mon, 3+ week ago   (435+ words) Royalty Pharma has agreed to acquire a portion of Neurimmune's royalty interest in AstraZeneca's cliramitug. Royalty Pharma will pay Neurimmune $125 million upfront, in return for a royalty of between 3% and 4% on worldwide net sales of cliramitug. A further $125 million in…...

1+ mon, 3+ week ago   (597+ words) The European regulator denied the company marketing authorization last year after Elevidys failed to meet endpoints. Roche partner Sarepta Pharmaceuticals recently announced it will launch its second attempt at a Phase III clinical trial for its gene therapy, Elevidys. The…...

1+ mon, 3+ week ago   (175+ words) Chai Discovery has raised $400 million in Series C financing, catapulting the San Fransico-based company to a valuation of $3.8 billion. Related:Gen Z's AI paradox: Why the most tech-savvy generation trusts healthcare AI the least The investment was led by Index…...

1+ mon, 4+ week ago   (379+ words) AstraZeneca has signed a licensing agreement with Dizal Pharmaceutical for lung cancer drug Zegfrovy, in a deal worth up to $1.5 billion. AstraZeneca will pay $600 million upfront and up to $900 million more tied to development, regulatory and sales milestones. In return,…...

1+ mon, 4+ week ago   (303+ words) Biotech firm Ocugen will expand its global footprint with the signing of a binding term sheet with Roots Pharmaceutical and its partner Al-Dhow International Holding. The deal structure also includes cumulative sales milestone payments reaching up to $255 million, alongside a…...

2+ mon, 3+ day ago   (238+ words) The biosimilar maker is using Alto Pharmacy as its digital partner for the new Sandoz Direct service. By all accounts and internet searches, Sandoz announced its new direct-to-patient platform solely on LinkedIn. Sandoz Direct went live in early July, offering…...

2+ mon, 6+ day ago   (427+ words) EY analysis highlights how outdated logistics hurt drug development timelines, increase waste, and compromise patient dosing in modern studies. Traditional distribution methods are struggling to cope with increasing complexity in clinical trials, according to EY, which suggests automated, predictive, tech-driven…...